External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASN Kidney Week 2023

-
Coming soon
02:00 PM
Duration 2hrs Philadelphia, USA
Baloxavir marboxil▼ (BXM) treatment of influenza in renally impaired patients (pts): post hoc analysis of CAPSTONE-2
Collins C, Cagas SE, Han J, Delporte ML, Retout S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:51 PM
Duration 9mins Philadelphia, PA
Kidney-related outcomes of patients with active lupus nephritis treated with obinutuzumab: a post-hoc analysis of the phase 2 NOBILITY trial
Rovin B, Terres J, Giang S, Schindler T, Turchetta A, Garg J, Furie R, Pendergraft W, Malvar A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:00 PM
Duration 2hrs Philadelphia, USA
Phase III COMMODORE trials of crovalimab in paroxysmal nocturnal hemoglobinuria (PNH): impact on kidney function
Sreckovic S, Brocchieri C, Leon P, Balachandran N, Ugen M, Buatois S

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar